{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:52:02Z","timestamp":1791503522166,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11475"],"award-info":[{"award-number":["25K11475"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.resinv.2026.101486","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:14:00Z","timestamp":1784218440000},"page":"101486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhaled granulocyte\u2013macrophage colony-stimulating factor for autoimmune pulmonary alveolar proteinosis: From pathogenesis to clinical practice"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-004X","authenticated-orcid":false,"given":"Ryushi","family":"Tazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101486_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1164\/rccm.2109105","article-title":"Pulmonary alveolar proteinosis: progress in the first 44 years","volume":"166","author":"Seymour","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib2","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1056\/NEJMra023226","article-title":"Pulmonary alveolar proteinosis","volume":"349","author":"Trapnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101486_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","article-title":"Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan","volume":"177","author":"Inoue","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.8171324","article-title":"Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis","volume":"264","author":"Dranoff","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.resinv.2026.101486_bib5","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","article-title":"Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology","volume":"91","author":"Stanley","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.resinv.2026.101486_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/1074-7613(95)90046-2","article-title":"Mice deficient for the IL-3\/GM-CSF\/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal","volume":"2","author":"Nishinakamura","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.resinv.2026.101486_bib7","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1056\/NEJM199612193352513","article-title":"Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis","volume":"335","author":"Seymour","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101486_bib8","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/S0021-9258(18)71855-3","article-title":"Purification and properties of colony-stimulating factor from mouse lung-conditioned medium","volume":"252","author":"Burgess","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2026.101486_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.resinv.2026.101486_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1164\/ajrccm.162.2.9910032","article-title":"Serological diagnosis of idiopathic pulmonary alveolar proteinosis","volume":"162","author":"Kitamura","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib11","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1056\/NEJMc0904077","article-title":"Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis","volume":"361","author":"Sakagami","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101486_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2026.101486_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0002-8703(33)90139-8","article-title":"The circulation time in various clinical conditions determined by the use of sodium dehydrocholate","volume":"8","author":"Tarr","year":"1933","journal-title":"Am Heart J"},{"key":"10.1016\/j.resinv.2026.101486_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-9149(71)90252-9","article-title":"The circulation time in the aged","volume":"27","author":"Willems","year":"1971","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.resinv.2026.101486_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/0277-5379(90)90053-V","article-title":"The effects of dose and route of the administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor","volume":"26","author":"Cebon","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.resinv.2026.101486_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cyto.2014.03.009","article-title":"Low concentrations of recombinant granulocyte macrophage-colony stimulating factor derived from Chinese hamster ovary cells augments long-term bioactivity with delayed clearance in vitro","volume":"68","author":"Hashimoto","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.resinv.2026.101486_bib16","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1182\/blood.V92.12.4491","article-title":"Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Armitage","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2026.101486_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V69.1.43.43","article-title":"Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor","volume":"69","author":"Burgess","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2026.101486_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.3923623","article-title":"Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins","volume":"228","author":"Wong","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.resinv.2026.101486_bib19","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1073\/pnas.82.18.6250","article-title":"Cloning, sequence, and expression of a human granulocyte\/macrophage colony-stimulating factor","volume":"82","author":"Cantrell","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2026.101486_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/ajrccm.163.2.2003146","article-title":"Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis","volume":"163","author":"Seymour","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood.V70.1.206.206","article-title":"Recombinant human GM-CSF induces leucocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates","volume":"70","author":"Mayer","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2026.101486_bib23","first-page":"191","article-title":"Sargramostim (Rhu GM-CSF) improves survival of non-human Primates with severe bone marrow suppression after acute, high-dose, whole-body irradiation","volume":"195","author":"Clayton","year":"2021","journal-title":"Radiat Res"},{"key":"10.1016\/j.resinv.2026.101486_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12931-024-03003-w","article-title":"Repeated inhalation of GM-CSF by nonhuman primates induces bronchus-associated lymphoid tissue along the lower respiratory tract","volume":"25","author":"Tazawa","year":"2024","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.resinv.2026.101486_bib25","article-title":"Pharmacokinetics and pharmacodynamics of inhaled molgramostim in healthy people","volume":"12","author":"Trapnell","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resinv.2026.101486_bib26","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V84.12.4078.bloodjournal84124078","article-title":"Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients","volume":"84","author":"Ragnhammar","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2026.101486_bib27","article-title":"Chronic inhalation of recombinant human granulocyte\/macrophage colony stimulating factor (GM-CSF) and GM-CSF antibody in nonhuman primates","volume":"195","author":"Tazawa","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1164\/ajrccm.161.4.9906044","article-title":"Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis","volume":"161","author":"Kavuru","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.130.1.227","article-title":"An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis","volume":"130","author":"Venkateshiah","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101486_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-1261-1","article-title":"Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101486_bib31","first-page":"L556","article-title":"Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice","volume":"276","author":"Reed","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.resinv.2026.101486_bib32","first-page":"2316","article-title":"Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung specific biological therapy in patients with lung metastases","volume":"5","author":"Anderson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2026.101486_bib33","article-title":"Aerosolized GM-CSF improves pulmonary function in idiopathic pulmonary alveolar proteinosis","volume":"161","author":"Wylam","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1164\/rccm.200406-716OC","article-title":"Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis","volume":"171","author":"Tazawa","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1183\/09031936.06.00058305","article-title":"Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis","volume":"27","author":"Wylam","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101486_bib36","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.200906-0978OC","article-title":"Inhaled granulocyte\/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis","volume":"181","author":"Tazawa","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101486_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1378\/chest.13-0603","article-title":"Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy","volume":"145","author":"Tazawa","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101486_bib38","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.rmed.2004.08.011","article-title":"Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF","volume":"98","author":"Arai","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101486_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1183\/09031936.00076711","article-title":"Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis","volume":"39","author":"Ohashi","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101486_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.rmed.2011.10.019","article-title":"Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis","volume":"106","author":"Ohashi","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101486_bib41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1816216","article-title":"Inhaled GM-CSF for pulmonary alveolar proteinosis","volume":"381","author":"Tazawa","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101486_bib42","first-page":"140","article-title":"Preliminary report on a sargramostim inhalation study for moderate to severe autoimmune alveolar proteinosis","volume":"13","author":"Nakata","year":"2024","journal-title":"Annals Jpn Respir Soc"},{"key":"10.1016\/j.resinv.2026.101486_bib43","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1913590","article-title":"Inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosis","volume":"383","author":"Trapnell","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101486_bib44","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMoa2410542","article-title":"Phase 3 trial of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis","volume":"393","author":"Trapnell","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101486_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13023-020-01450-4","article-title":"Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis\u2014a six month phase II randomized study with 24 months of follow-up","volume":"15","author":"Tian","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.resinv.2026.101486_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01233-2023","article-title":"Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients","volume":"63","author":"Campo","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101486_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40261-014-0208-z","article-title":"Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose","volume":"34","author":"Papiris","year":"2014","journal-title":"Clin Drug Invest"},{"issue":"Suppl","key":"10.1016\/j.resinv.2026.101486_bib48","first-page":"S61","article-title":"Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report","volume":"11","author":"Tazawa","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101486_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01982-2023","article-title":"Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner","volume":"63","author":"Bonella","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101486_bib50","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1513\/AnnalsATS.201611-892BC","article-title":"Sequential granulocyte-macrophage colony-stimulating factor inhalation after whole-lung lavage for pulmonary alveolar proteinosis. A report of five intractable cases","volume":"14","author":"Ohkouchi","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2026.101486_bib51","series-title":"The JRS clinical practice guideline for pulmonary alveolar proteinosis 2022","author":"Inoue","year":"2022"},{"key":"10.1016\/j.resinv.2026.101486_bib52","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2024","article-title":"European respiratory society guidelines for the diagnosis and management of pulmonary alveolar proteinosis","volume":"64","author":"McCarthy","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101486_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/resp.70048","article-title":"A new Era in the treatment of autoimmune pulmonary alveolar proteinosis","volume":"30","author":"Tazawa","year":"2025","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101486_bib54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13023-026-04274-w","article-title":"A long-term observational study on autoimmune pulmonary alveolar proteinosis revealed a sustained and generalized decrease in serum autoantibody levels","volume":"21","author":"Yamaguchi","year":"2026","journal-title":"Orphanet J Rare Dis"}],"updated-by":[{"DOI":"10.1016\/j.resinv.2026.101506","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:25:20Z","timestamp":1791501920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2212534526001206"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101486","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled granulocyte\u2013macrophage colony-stimulating factor for autoimmune pulmonary alveolar proteinosis: From pathogenesis to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101486"}}